CST3 Gene Cerebral amyloid angiopathy Genetic Test
At DNA Labs UAE, we offer the CST3 Gene Cerebral amyloid angiopathy Genetic Test at a cost of AED 4400.0. This test is designed to diagnose and provide information about the risk of developing cerebral amyloid angiopathy, a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain.
Test Components
- Price: AED 4400.0
Sample Condition
The sample required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test report will be delivered within 3 to 4 weeks.
Method
The CST3 Gene Cerebral amyloid angiopathy Genetic Test utilizes NGS (next-generation sequencing) technology.
Test Type
This test falls under the category of Neurological Disorders.
Doctor
This test is conducted by a Neurologist.
Test Department
The CST3 Gene Cerebral amyloid angiopathy Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the CST3 Gene Cerebral amyloid angiopathy NGS Genetic DNA Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with CST3 Gene Cerebral amyloid angiopathy.
Test Details
The CST3 gene is associated with cerebral amyloid angiopathy, a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain. This can result in damage to the blood vessels and impairments in cognitive function.
NGS genetic testing is used to analyze the CST3 gene and identify any mutations or variations that may be associated with cerebral amyloid angiopathy. This type of testing aids in the diagnosis of the condition and provides information about the risk of developing it in the future. It can also guide treatment and management strategies for individuals with cerebral amyloid angiopathy.
Test Name | CST3 Gene Cerebral amyloid angiopathy Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CST3 Gene Cerebral amyloid angiopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CST3 Gene Cerebral amyloid angiopathy |
Test Details | The CST3 gene is associated with cerebral amyloid angiopathy, which is a condition characterized by the accumulation of amyloid protein in the walls of blood vessels in the brain. This can lead to damage to the blood vessels and impairments in cognitive function. NGS (next-generation sequencing) genetic testing can be used to analyze the CST3 gene and identify any mutations or variations that may be associated with cerebral amyloid angiopathy. This type of testing can help to diagnose the condition and provide information about the risk of developing it in the future. It may also be used to guide treatment and management strategies for individuals with cerebral amyloid angiopathy. |